Maxygen Says It Will Liquidate, Pay Off Shareholders
California-based biopharmaceutical company Maxygen Inc. announced Monday that it will liquidate and dissolve following a first-quarter net loss of $2.1 million, saying it will distribute all available cash to shareholders after...To view the full article, register now.
Already a subscriber? Click here to view full article